Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Business Development
Sort By
Newest First
1 / 1
1 / 1
Business Leadership
Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer
Wheeler Bio
PR-M08-23-01
Aug 15, 2023
Social Media Marketing
Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?
Pharma's Almanac
PA741
Oct 11, 2021
Social Media Marketing
Q: How is your organization using social media to extend your marketing efforts?
Pharma's Almanac
PAO-06-21-RT-2
Jun 15, 2021
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
Nicholas Green
Avid Bioservices
PAO-05-21-CL-03
May 12, 2021
Business Development
Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?
Pharma's Almanac
PAO-03-21-NI-02
Mar 16, 2021
Business Development
Strategizing for International Business Development
Erica Sosnowski
Sosna & Co.
PAP-Q3-19-CL-029
Oct 28, 2019
Facilitating Acquisitions
Facilitating Pharmaceutical and Biotech Facility Acquisitions
Sean McKee
PharmaBioSource, Inc.
PAP-Q3-19-CL-021
Oct 28, 2019
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
The Polsky Center for Entrepreneurship and Innovation
PR-M07-19-NI-047
Jul 17, 2019
Announcement
GSK Announces Changes to Their Sales Representative Incentive Program
GSK
PR-M05-19-NI-083
May 30, 2019
Business Development
Running a CDMO Business is Hard – So Now Let’s Talk about Value Creation
Eric Mattson
Excellere Partners
PAP-Q2-2019-CL-015
May 24, 2019
Launch
Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S.
Piramal Pharma Ltd.
PR-M03-19-NI-034
Mar 13, 2019
Attracting Investment
Preparing Middle-Market Firms to Attract Investment
Jeffrey Marlough
Castleford Capital
PAP-Q1-2019-CL-007
Mar 12, 2019
Q of E
Quality of Earnings: The Most Important Term You Probably Don’t Know
Eric Mattson; Michael Geldart
Excellere Partners
PAP-Q1-2019-CL-022
Mar 12, 2019
Consolidation
Factors Driving Consolidation in the CDMO Space
Jason Foss
Results Healthcare
PAP-Q1-2019-CL-023
Mar 12, 2019
Leveraging Expertise
Similar, Different and Constantly Varied
Steve King
PAP-Q1-2019-CL-021
Mar 12, 2019
The U.K. Market
U.K. Healthcare Firms Creating Value Worldwide
Hemavli Bali
Clearwater International
PAP-Q1-2019-CL-027
Mar 12, 2019
Risk Management
The Value Triangle: Risk Management for RMATs
John Wass
CAI Commissioning Agents Inc.
PAP-Q1-2019-CL-018
Mar 12, 2019
Generics
Finding the Right Product Platform: A Personal Perspective
Ori Gutwerg
Taro Pharmaceutical Industries
PAP-Q1-2019-CL-034
Mar 12, 2019